Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Diagnostic features of multiple organic system disorders associated with COVID-19 in a child of primary school age ; Особенности диагностики полиорганных нарушений, ассоциированных с COVID-19, у ребёнка младшего школьного возраста

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Publication Information:
      IPO “АIDSSPbR"
    • Publication Date:
      2023
    • Collection:
      Journal Infectology / Журнал инфектологии
    • Abstract:
      The advent of the COVID-19, specialists are increasingly encountering previously unknown pathological conditions in their practice. For some time, we have believed that COVID-19 in children is most often mild and asymptomatic. However, with the passage of time and the accumulation of the experience, it became obvious that the new infectious disease it will be quite severe in children. Differential diagnosis of multiple organ disorders in children during the COVID-19 pandemic should be primary carried out with the Multisystem Inflammatory Syndrome in Children, associated with COVID-19 (MIS-C), as well as Long-COVID-19. According to published data, the manifestations of these conditions are due to frequent lesions of the gastrointestinal tract (60–100 %), cardiovascular (80 %), nervous (29–58 %) and respiratory (21–65 %) systems. At present, there is no exact idea of these pathological conditions, the criteria for their diagnosis and the tactics of managing children, not only at the stage of diagnosis, but also at the stage of observation. The authors present a diagnostically complex clinical case describing the development of multiple organ damage in a 7-year-old child after contact with a mother who was sick with COVID-19. The data on the course features, the results of the examination and the difficulties of differential diagnosis of this case with other diseases with a similar clinic are summarized. ; С появлением COVID-19 специалисты все чаще встречаются в своей практике с ранее неизвестными патологическими состояниями. Некоторое время считалось, что COVID-19 у детей протекает чаще всего в легкой и бессимптомной форме. Однако с течением времени и накоплением опыта стало очевидным, что новое инфекционное заболевание достаточно коварно и в отношении детского населения. Дифференциальная диагностика полиорганных нарушений у детей во время пандемии COVID-19 прежде всего должна проводиться с мультисистемным воспалительным синдромом у детей, ассоциированным с COVID-19 (Multisystem Inflammatory Syndrome in Children, ...
    • File Description:
      application/pdf
    • Relation:
      https://journal.niidi.ru/jofin/article/view/1431/1026; Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395 (10223): 497-506. doi:10.1016/S0140-6736(20)30183-5.; Старшинова, А. А. Новая коронавирусная инфекция: особенности клинического течения, возможности диагностики, лечения и профилактики инфекции у взрослых и детей / А. А. Старшинова [и др.] // Вопросы современной педиатрии. – 2020. – № 19 (2). – С. 42–50.; WHO. Coronavirus disease (COVID-19) pandemic. Geneva: WHO; 2020. Available from: https://www.who.int/europe/emergencies/situations/covid-19.; Kompaniyets L., Bull-Otterson L., Boehmer K. T., Sarah Baca S., Alvarez P., Hong K. et al. Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022. MMWR. 2022; 71 (31): 993-999. DOI:10.15585/mmwr.mm7131a3.; Liu K., Fang Y. Y., Deng Y., Liu W., Wang M. F., Ma J. P. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. 2020; 133 (9): 1025-1031. doi:10.1097/CM9.0000000000000744.; Yong Sh. J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments, Infectious Diseases, 2021. 53: 10, 737-754, DOI:10.1080/23744235.2021.1924397.; Malkova A. M., Kudlai D. A., Kudryavtsev I. V., Starshinova A. A., Yablonsky P. K., Shoenfeld Y. Immunogenetic predictors of severe COVID-19. Vaccines. 2021; 9 (3): 211. DOI:10.3390/vaccines9030211.; Wang L., Berger N. A., Kaelber D. C., Pamela B. Davis P. B., Volkow N. D., Xu R. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron. MedRxiv and bioRxiv. 2022. doi:10.1101/2021.12.30.21268495.; Price A. M., Olson S. M., Newhams M. M., Halasa N. B., Boom J. A., Sahni L. C., Pannaraj P. S. et al. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. The NEJM.org. 2022. DOI:10.1056/NEJMoa2202826.; Starshinova A. A., Malkova A. M., Zinchenko Yu. S., Kudlai D. A., Glushkova A. V., Dovgalyk I. et al. Efficacy of different types of therapy for covid-19: a comprehensive review. Life. 2021; 11 (8): 753. doi:10.3390/life11080753; Мелехина, Е. В. Клинические особенности течения COVID-19 у детей различных возрастных групп / Е. В. Мелехина, А. В. Горелов, А. Д. Музыка // Обзор литературы к началу апреля 2020 года. Вопросы практической педиатрии. – 2020. – № 15 (2). – С. 7–20. DOI:10.20953/1817-7646-2020-2-7-20; Tagarro A., Epalza С., Santos M., et al. Screening and severity of Coronavirus disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr. 2020; e201346. doi:10.1001/jamapediatrics.2020.1346.; Козлов, В. А. Клиническая иммунология : практическое пособие для инфекционистов / В. А. Козлов [и др.]. – Красноярск: Поликор, 2021. – 563 c.; Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021 Jul; 180 (7): 2019-2034. doi:10.1007/s00431-021-03993-5.; Center for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) 2021. https://www.cdc.gov/mis-c/cases. Accessed 18 Mar 2022.; Centers for Disease Control and Prevention. MIS-C and COVID-19. Available online: https://www.cdc.gov/mis-c/ (accessed on 15 January 2022).; Royal College of Paediatrics and Child Health Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19. https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance (accessed on 15 January 2022).; Jiang L., Tang K., Irfan O., Li X, Zhang E., Bhutta Z. Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents-a Live Systematic Review and Meta-analysis. Curr Pediatr Rep. 2022; 10 (2): 19-30. doi:10.1007/s40124-022-00264-1.; Irfan O., Muttalib F., Tang K., Jiang L., Lassi Z. S., Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Arch Dis Child. 2021 Feb 16;106(5):440–8. doi:10.1136/archdischild-2020-321385.; Radia T., Williams N., Agrawal P., Harman K., Weale J., Cook J., Gupta A. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev. 2021; 38: 51-57. doi:10.1016/j.prrv.2020.08.001; Castagnoli R., Votto M., Licari A., Brambilla I., Bruno R., Perlini S., Rovida F., Baldanti F., Marseglia G. L. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020; 174 (9): 882-889. doi:10.1001/jamapediatrics.2020.1467.; Dolinger M. T., Person H., Smith R., Jarchin L., Pittman N., Dubinsky M. C., Lai J. Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab. J Pediatr Gastroenterol Nutr. 2020; 71 (2): 153-155. doi:10.1097/MPG.0000000000002809.; NICE. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE); London, UK: 2020; Miller F., Nguyen V., Navaratnam A. M., Shrotri M., Kovar J., Hayward A. C., Fragaszy E., Aldridge R. W., Hardelid P. Prevalence of persistent symptoms in children during the COVID-19 pandemic: Evidence from a household cohort study in England and Wales. medRxiv. 2021 doi:10.1101/2021.05.28.21257602; Koc H. C., Xiao J., Liu W., Li Y., Chen G. Long COVID and its Management. Int J Biol Sci. 2022 Jul 11; 18 (12): 4768-4780. doi:10.7150/ijbs.75056; Boston Children’s Hospital Z-Score Calculator: https://pedz.de/de/pedz/main.html (Last access July 2020).; Whittaker E., Bamford A., Kenny J., et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA2020; 324: 259. doi:10.1001/jama.2020.10369; Кантемирова, М. Г. Детский мультисистемный воспалительный синдром, ассоциированный с новой коронавирусной инфекцией (COVID-19): актуальная информация и клиническое наблюдение / М. Г. Кантемирова [и др.] // Педиатрическая фармакология. – 2020. – № 17 (3). – С. 219–229.; Stafie C. S., Solomon S. M., Sufaru I. G., Manaila M., Stafie I. I., Melinte G., Simionescu B., Leustean L. Pathogenic Connections in Post-COVID Conditions: What Do We Know in the Large Unknown? A Narrative Review. Viruses. 2022 Jul 30; 14 (8): 1686. doi:10.3390/v14081686.; Malkova A., Kudryavtsev I., Starshinova A., Kudlay D., Zinchenko Y., Glushkova A., Yablonskiy P., Shoenfeld Y. Post COVID-19 Syndrome in Patients with Asymptomatic / Mild Form. Pathogens. 2021 Oct 30; 10 (11): 1408. doi:10.3390/pathogens10111408.; Turner, S., Naidoo, C. A., Usher, T. J., et al. (2022). Increased levels of inflammatory molecules in blood of Long COVID patients point to thrombotic endotheliitis. medRxiv. doi:10.1101/2022.10.13.22281055.; Gustine J. N., Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Pathol. 2021 Jan; 191 (1): 4-17. doi:10.1016/j.ajpath.2020.08.009.; Wangu Z., Swartz H., Doherty M. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. BMJ Case Rep. 2022; 15 (3): e247176. doi:10.1136/bcr-2021-247176.; Valverde I., Singh Y., Sanchez-de-Toledo J. et al. AEPC COVID-19 Rapid Response Team. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory SyndromeAssociated With COVID-19 Infection in Europe. Circulation. 2021; 143 (1): 21–32. doi:10.1161/CIRCULATIONAHA.120.050065.; Kaushik S., Aydin S. I., Derespina K. R. et al (2020) Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection: a multi-institutional study from New York City. J Pediatr 2-7. doi:10.1016/j.jpeds.2020.06.045.; Salamanna F., Veronesi F., Martini L., Landini M. P., Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne). 2021 May 4; 8: 653516. doi:10.3389/fmed.2021.653516. PMID: 34017846; Rao S., Lee G. M., Razzaghi H., Lorman V., Mejias A., Pajor N. M., Thacker D., Webb R., Dickinson K., Bailey L. C., Jhaveri R., Christakis D. A., Bennett T. D., Chen Y., Forrest C. B. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022 Oct 1; 176 (10): 1000-1009. URL: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1999806; https://journal.niidi.ru/jofin/article/view/1431
    • Accession Number:
      10.22625/2072-6732-2022-14-5-90-100
    • Online Access:
      https://doi.org/10.22625/2072-6732-2022-14-5-90-100
      https://doi.org/10.22625/2072-6732-2022-14-5
      https://doi.org/10.1016/S0140-6736(20)30183-5
      https://doi.org/10.15585/mmwr.mm7131a3
      https://doi.org/10.1097/CM9.0000000000000744
      https://doi.org/10.1080/23744235.2021.1924397
      https://doi.org/10.3390/vaccines9030211
      https://doi.org/10.1101/2021.12.30.21268495
      https://doi.org/10.1056/NEJMoa2202826
      https://doi.org/10.3390/life11080753
    • Rights:
      Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access).
    • Accession Number:
      edsbas.AF88920E